Mark Kotter is at the forefront of transitioning biology to engineering. He is a doctor, scientist and serial entrepreneur. Mark’s work is addressing many of the most important human needs, including cancer and the consequences of poor health due to ageing. His company Bit.bio made an important announcement earlier this year with the launch of a powerful new toolset for programming STEM cells. It’s hard to overstate the implications of this technology, and the pathways it suggests for regeneration and repairing organs in the human body, enhancement with new cells, and growing or printing new organs. Mark is the founder of Bit.bio, co-founder of cultured meat startup Meatable, anti-ageing start-up Clock.bio, and co-founder and trustee of spinal cord injury charity Myelopathy.org.